Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TFPI | P10646 | 6/20 | 0.58 |
| ▸ | BECN1 | Q14457 | 4/20 | 0.52 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.50 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.50 |
| ▸ | VIPR1 | P32241 | 2/20 | 0.49 |
| ▸ | VIPR2 | P41587 | 2/20 | 0.49 |
| ▸ | GLP1R | P43220 | 2/20 | 0.49 |
| ▸ | NPY1R | P25929 | 1/20 | 0.48 |
| ▸ | NPY2R | P49146 | 1/20 | 0.48 |
| ▸ | NPY4R | P50391 | 1/20 | 0.48 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29727699 | 0.84 | OPRL1 (0.43) | TFPIBECN1HCRTR1HCRTR2 | |
| SCHEMBL10743964 | 0.84 | TFPI (0.51) | TFPI | |
| SCHEMBL16922391 | 0.84 | TFPI (0.65) | TFPIGLP1R | |
| SCHEMBL10741300 | 0.84 | TFPI (0.51) | TFPI | |
| SCHEMBL30974383 | 0.83 | TFPI (0.55) | TFPIVIPR1VIPR2GLP1R | |
| Nonathymulin SCHEMBL2109423 | 0.82 | OPRL1 (0.42) | TFPIHCRTR1HCRTR2 | |
| Nonathymulin SCHEMBL29727660 | 0.82 | OPRL1 (0.42) | TFPIHCRTR1HCRTR2 | |
| SCHEMBL30082750 | 0.82 | TFPI (0.57) | TFPIVIPR1VIPR2NPY1RNPY2R | |
| SCHEMBL29354356 | 0.82 | TFPI (0.57) | TFPIVIPR1VIPR2NPY1RNPY2R | |
| SCHEMBL10744274 | 0.81 | OPRL1 (0.42) | TFPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3395372-B1 | GLUTATHIONE-BASED DRUG DELIVERY SYSTEM | ENHANX BIOPHARM INC (TW) | 2022-04-06 | — | — | EP | disclosed |